Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/208111
Title: | Permeation Protection by Waterproofing Mucosal Membranes |
Author: | Coderch Negra, Ma. Luisa Alonso, Cristina Calpena Campmany, Ana Cristina Pérez García, M. Lluïsa (Maria Lluïsa) Clares Naveros, Beatriz Ramos, Anderson Martí, Meritxell |
Keywords: | Membrana mucosa Mucosa gastrointestinal Mucous membrane Gastrointestinal mucosa |
Issue Date: | 29-Nov-2023 |
Publisher: | MDPI |
Abstract: | <p>The permeability of the oral or nasal mucosa is higher than that of the skin. Mucosa permeability</p><p>depends mainly on the thickness and keratinization degree of the tissues. Their permeability</p><p>barrier is conditioned by the presence of certain lipids. This work has the main aim of reinforcing the</p><p>barrier effect of oral mucosa with a series of formulations to reduce permeation. Transmembrane</p><p>water loss of different formulations was evaluated, and three of them were selected to be tested on</p><p>the sublingual mucosa permeation of drugs. Caffeine, ibuprofen, dexamethasone, and ivermectin</p><p>were applied on porcine skin, mucosa, and modified mucosa in order to compare the effectiveness of</p><p>the formulations. A similar permeation profile was obtained in the different membranes: caffeine</p><p>> ibuprofen~dexamethasone > ivermectin. The most efficient formulation was a liposomal formulation</p><p>composed of lipids that are present in the skin stratum corneum. Impermeability provided</p><p>by this formulation was notable mainly for the low-molecular-weight compounds, decreasing their</p><p>permeability coefficient by between 40 and 80%. The reinforcement of the barrier function of mucosa</p><p>provides a reduction or prevention of the permeation of different actives, which could be extrapolated</p><p>to toxic compounds such as viruses, contaminants, toxins, etc.</p> |
Note: | Reproducció del document publicat a: https://doi.org/https://doi.org/10.3390/pharmaceutics15122698 |
It is part of: | Pharmaceutics, 2023, vol. 15, p. 2698 |
URI: | http://hdl.handle.net/2445/208111 |
Related resource: | https://doi.org/https://doi.org/10.3390/pharmaceutics15122698 |
ISSN: | 1999-4923 |
Appears in Collections: | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
836630.pdf | 2.77 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License